BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200707
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T101316
CREATED:20200520T091348Z
LAST-MODIFIED:20200520T091348Z
UID:25596-1594080000-1594339199@www.pharmajournalist.com
SUMMARY:Onco Cell Therapy Summit
DESCRIPTION:Onco Cell Therapy Summit (OCTS)\, formerly the CAR-T Congress\, is the leading digital event revolutionizing patient outcomes in cancer therapies. \nThis virtual summit\, taking place June 7 – 9\, spans across 3 half days\, bringing you opportunities to share novel research\, manufacturing techniques and regulatory best practice through virtual panel discussion\, traditional presentations\, polls and round tables\, all from the comfort of your own home. Each session at OCTS 2020 is dedicated to encouraging knowledge sharing and translating novel data assets and IP into commercially viable oncological therapies. \n \nOCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies\, it also focuses on ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments. \nWith 2 of our tracks comprised of research on CAR-T and alternative cell therapies\, the other pillar in rolling out these therapies is increasing the affordability of the treatments. The other two tracks will delve into best practice in commercialization and manufacturing of immuno-oncological cell therapies. \nEach day includes plenty of opportunities to network and there’s multiple panel discussions to also take a deep dive into the key challenges in major topics to R&D\, manufacturing and commercialization. \nThis is one must attend virtual event in the cell therapy field.
URL:https://www.pharmajournalist.com/event/onco-cell-therapy-summit/
LOCATION:Virtual\, EDT Timezone
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200709
DTEND;VALUE=DATE:20200710
DTSTAMP:20260515T101316
CREATED:20200619T121040Z
LAST-MODIFIED:20200619T121040Z
UID:25993-1594252800-1594339199@www.pharmajournalist.com
SUMMARY:Direct to Patient and Virtual Clinical Trials – Digital Experience
DESCRIPTION:With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going\, we at Arena International are delighted to announce the launch of our Direct to Patient and Virtual Clinical Trials Digital Experience. \n \nThis one-day online event will bring together top-class speakers from around the world to discuss themes including remote monitoring\, temperature control in direct-to-patient shipments\, regulations and compliance\, and how to engage patients throughout a virtual trial. \nAlongside listening to presenters in our auditorium\, attendees will have the opportunity to visit our virtual exhibition hall\, chat in our networking lounge\, and set up 1:1 business meetings. \nThis event will be a crucial platform for clinical trials professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world\, making it an unmissable event in your calendar.
URL:https://www.pharmajournalist.com/event/direct-to-patient-and-virtual-clinical-trials-digital-experience/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International":MAILTO:Kadin.luong@arena-international.com
END:VEVENT
END:VCALENDAR